Details for 2008861526
Up to date per 03.04.2026
Actions
Details for 2008861526
Granted/Registered
European Patent
29.09.2010 A
06.09.2017 B1
19.12.2007
WO
PCT/SE2007/001127
A61K 38/13 20060101AFI20170217BHEP
Owner
Oasmia Pharmaceuticals ABVallongatan 1752 28 Uppsala, StockholmSE
Representative
Representative
Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT
Inventor
ALEKSOV, JulianKarins Allé 6 S-181 44 LidingöSE
LOKOT, IgorFerlinsgatan 59 nb S-754 28 UppsalaSE
Information about Fees